RUMORED BUZZ ON DICLOFENAC SODIUM

Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI difficulties due to the inhibition in the synthesis of gastroprotective brokers for example PGE2 together with other prostaglandins. This inhibition results in reduced mucin generation by gastric epithelial cells, significantly less bicarbonate secretion, and fewer ep